Accumulated facts, present day, yes.
William Gartner is trying to start up a business that sells DR-70 on the internet as a Lung Cancer Test. In 2012, he created a company called Global Cancer Diagnostics (GCDx) and built a website that you can still find today. Then he signed an agreement in 2012 with Radient to license DR-70, but his funding fell through, and that agreement was cancelled.
Then he pitched this business plan at AZ Bio the following spring.
Then he pitched this business plan on Fundable, but stopped after raising only $200.
Send an email to GCDx -- you won't get an answer. Try to leave them a voice mail -- their mail box is full.
Those are the facts. That's as "present day" as it gets for GCDx.
Anything else is conjecture. Personally, I think Gartner's business plan looks better to potential investors if Radient just disappears. In six weeks, Radient's last patent for DR-70 expires, and GCDx has no use for Radient. GCDx, or anyone else, can manufacture and sell the test without permission or licensing from Radient.
In six weeks, Radient will have NO ASSETS other than a pinksheet listing and a patent for CIT, a product that Radient said in their last 10-K is worthless. Those are the accumulated facts. That is "present day" for Radient.
No entity is going to take over a company that has no assets. The takeover rumor is just silly.
